Author
Listed:
- Silvio Alessandro Di Gioia
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School)
- Samantha Connors
(Dunedin School of Medicine, University of Otago)
- Norisada Matsunami
(University of Utah School of Medicine)
- Jessica Cannavino
(and Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center)
- Matthew F. Rose
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Boston Children’s Hospital
Medical Genetics Training Program, Harvard Medical School)
- Nicole M. Gilette
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital)
- Pietro Artoni
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School)
- Nara Lygia de Macena Sobreira
(McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine)
- Wai-Man Chan
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School
Howard Hughes Medical Institute)
- Bryn D. Webb
(Icahn School of Medicine at Mount Sinai)
- Caroline D. Robson
(Boston Children’s Hospital
Harvard Medical School)
- Long Cheng
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School)
- Carol Van Ryzin
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health)
- Andres Ramirez-Martinez
(and Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center)
- Payam Mohassel
(Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health
Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health)
- Mark Leppert
(University of Utah School of Medicine)
- Mary Beth Scholand
(University of Utah School of Medicine)
- Christopher Grunseich
(Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health)
- Carlos R. Ferreira
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health)
- Tyler Hartman
(Dartmouth-Hitchcock Medical Center, Geisel School of Medicine)
- Ian M. Hayes
(Genetic Health Services New Zealand, Auckland City Hospital)
- Tim Morgan
(Dunedin School of Medicine, University of Otago)
- David M. Markie
(Dunedin School of Medicine, University of Otago)
- Michela Fagiolini
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School)
- Amy Swift
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health)
- Peter S. Chines
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health)
- Carlos E. Speck-Martins
(SARAH Network of Rehabilitation Hospitals)
- Francis S. Collins
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health
Office of the Director, National Institutes of Health)
- Ethylin Wang Jabs
(McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
Icahn School of Medicine at Mount Sinai)
- Carsten G. Bönnemann
(Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health
Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health)
- Eric N. Olson
(and Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center)
- John C. Carey
(University of Utah School of Medicine)
- Stephen P. Robertson
(Dunedin School of Medicine, University of Otago)
- Irini Manoli
(Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health)
- Elizabeth C. Engle
(Boston Children’s Hospital
F.M. Kirby Neurobiology Center, Boston Children’s Hospital
Harvard Medical School
Medical Genetics Training Program, Harvard Medical School)
Abstract
Multinucleate cellular syncytial formation is a hallmark of skeletal muscle differentiation. Myomaker, encoded by Mymk (Tmem8c), is a well-conserved plasma membrane protein required for myoblast fusion to form multinucleated myotubes in mouse, chick, and zebrafish. Here, we report that autosomal recessive mutations in MYMK (OMIM 615345) cause Carey-Fineman-Ziter syndrome in humans (CFZS; OMIM 254940) by reducing but not eliminating MYMK function. We characterize MYMK-CFZS as a congenital myopathy with marked facial weakness and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes. We show that a heterologous cell fusion assay in vitro and allelic complementation experiments in mymk knockdown and mymkinsT/insT zebrafish in vivo can differentiate between MYMK wild type, hypomorphic and null alleles. Collectively, these data establish that MYMK activity is necessary for normal muscle development and maintenance in humans, and expand the spectrum of congenital myopathies to include cell-cell fusion deficits.
Suggested Citation
Silvio Alessandro Di Gioia & Samantha Connors & Norisada Matsunami & Jessica Cannavino & Matthew F. Rose & Nicole M. Gilette & Pietro Artoni & Nara Lygia de Macena Sobreira & Wai-Man Chan & Bryn D. We, 2017.
"A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome,"
Nature Communications, Nature, vol. 8(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16077
DOI: 10.1038/ncomms16077
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16077. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.